EMMAC Life Sciences | European Medical Cannabis Company

Medical Cannabis

EMMAC is bringing together the latest science and research into the medical benefits of cannabis with pioneering cultivation, extraction and production to establish itself as the European leader in the production and supply of medical cannabis.

Research

EMMAC is at the forefront of the global medical cannabis industry working with research institutions to deliver clinical data regarding the efficacy of medical cannabis for pain and the potential public health benefits for patients.

CBD and Cannabinoids

EMMAC is capitalising on the rapidly growing CBD and cannabinoids market across Europe, leveraging its genetics and its technology and working on the benefits of CBD and other cannabinoids that are extracted from the cannabis plant.

Imperial College London & EMMAC Life Sciences

EMMAC announces pioneering research collaboration with Imperial College London

The partnership between EMMAC and Imperial College London has been forged to deliver a long-term comprehensive research programme designed to shape the future of the medical cannabis therapeutic industry.

View the press release

Find out more

EMMAC’s European Operations

EMMAC has developed unique supply and distribution partnerships across Europe to establish itself not only as a thought leader at the very forefront of research into the medical benefits of cannabis but also a European leader in the production and supply of medical cannabis, hemp and other derivative products.

Leadership Team

EMMAC Across Europe

EXPERIENCE & EXPERTISE

Leveraging decades of medical cannabis experience through a highly skilled board of advisors, management and consultants

Events & Press Releases

Upcoming Events

5th International Emerald Conference

28th February, 2019

For more information, visit: https://www.theemeraldconference.com

Press Releases

Medalchemy, EMMAC’s Spanish GMP certified laboratory, secures approval to import medical cannabis for scientific research

19 March 2019, London: EMMAC, the European independent medical cannabis company, is pleased to announce that Medalchemy, EMMAC’s fully-licensed GMP certified laboratory in Alicante, Spain, has secured approval from

£11 million raised via successful Private Placing

‘Oversubscribed placing with institutional investment from across Europe, North America, Asia and Australia’ 8 March 2019, London. EMMAC Life Sciences Limited, the European independent medical cannabis company, is pleased

EMMAC to present preliminary work on clinical trial design at 5th International Emerald Conference

EMMAC is pleased to announce that the Company will be presenting collaborative work with Imperial College at the 5th International Emerald Conference in San Diego on the 28th of February.

EMMAC Life Sciences
Audley House, 12-12a Margaret Street, London, W1W 8RH
[email protected]

The European Independent Medical Cannabis Company